PharmExec Direct: Having trouble viewing the email? Click Here

In this ISSUE

Tax Overhaul: A Plus for Pharma

Is Brexit Really Top of Pharma's New Year "To-Do" List?

Targeting KOLs with Data

Advertisement
Top Story
New Year, Next Steps in Digital Transformation
William King offers five predictions on the evolution of data and predictive insights that could be critical for pharma go-to-market strategies
/Read more/
Advertisement
Regulatory Information Management Best Practices
Read this Executive Summary to learn how to reduce regulatory complexity, ensure data quality and improve the user experience while ensuring compliance.
Download Now
Interview
Advancing Immuno-oncology: The CytomX Story
Sean McCarthy, President & CEO of CytomX, talks to Pharm Exec about the company's journey from university startup to rising star of the immuno-oncology space
/Read more/
Advertisement
GDPR: Implications for the global Life Sciences industry
On Demand
Learn more
Collaboration
Furthering Your R&D Budget While Boosting Innovation
Industry stakeholders must share the costs of R&D, ensuring it has maximum benefit to their company and the industry as a whole, writes Dr. Steve Arlington
/Read more/
ADVERTISEMENT
Calendar
/ January 23–24, 2018: 13th Biosimilars Summit /
Alexandria, VA
/ January 24–25, 2018: Reimbursement and Contracting /
Philadelphia, PA
/ February 7–8, 2018: Speaker Programs 2018 /
Philadelphia, PA
/ March 25–28, 2018: 14th Annual Pharma Forum /
Philadelphia, PA
/ March 28–29, 2018: Expanded Access Programs /
Washington, DC
/ April 10–12, 2018: LogiPharma 2018 /
Montreux, Switzerland
/ April 11–12, 2018: 8th Annual Global Transparency Reporting Congress /
London, UK
/ May 10–11, 2018: Pharma Marketing Summit /
Palm Beach, FL
/ October 15–17, 2018: 28th Annual Sharing Conference: Compliance /
National Harbor, MD
Global Health
Fighting the Good Fight
Pharm Exec details the latest approaches to combating disease and health crises on a global scale—including industry perspectives from those involved on the front lines
/Read more/
Industry update
// Eloxx Pharmaceuticals (Waltham, MA) named Robert "Bob" Ward as Chairman of the Board of Directors and Chief Executive Officer. // Carl Roland, Senior Director at Pfizer, has been selected to join the Industry Board at the American Health Council (New York, NY). // Blake Wise, formerly President and Chief Operating Officer of Achaogen (South San Francisco, CA), succeeded Kenneth Hillan as the company's Chief Executive Officer on January 1. // INC Research/inVentiv Health (Raleigh, NC) appointed Michelle Keefe as President, Commercial Solutions. // Tetraphase Pharmaceuticals (Watertown, MA) appointed Larry Tsai, M.D. to Chief Medical Officer. //
 
advertise with us / print subscribe / digital subscribe / visit pharmexec.com